UniDoc Introduces Artificial Intelligence (AI) Integration

AI software adds powerful diagnostic monitoring and assessment features and benefits.

VANCOUVER, BC / ACCESSWIRE / July 17, 2023 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTC PINK:UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, is pleased to announce the adoption of artificial intelligence (AI) technology into its innovative eHealth virtual clinic kiosk designed for private patient and physician consultations in public spaces.

Key Highlights:

  • UniDoc implementing AI to Virtual Care Solutions Model (“VCSM”) platform
  • AI and Predictive Algorithms to leverage proven Intensive Care Unit (ICU) solutions

To facilitate the integration of AI technology, UniDoc entered into a memorandum of understanding agreement on June 7, 2023 with Texas based DocBox Inc. (“DocBox”) for the implementation of an integration pathway regarding the TriAge Assistant, a proven open Internet of Medical Things (“IoMT”) platform for remote real-time clinical monitoring.

UniDoc CEO Antonio Baldassare notes, “By blending the DocBox AI and predictive algorithms with our state-of-the-art diagnostics, high-speed access, and high-definition communications equipment, the UniDoc platform is predicted to enhance connectivity and productivity between doctors, clinicians, and patients enabling faster access to high-quality care through the adoption and deployment of the very latest eHealth innovations.”

The TriAge Assistant has the potential to enhance the way doctors provide care to patients. Leveraging advanced AI and predictive analytics algorithms, combined with its ability to collect and securely store data from various sources, including medical devices, and primary care observations, the platform analyzes the data to offer valuable insights for clinical and operational decision-making. With these insights, doctors and healthcare providers can make more informed choices about their patients’ care and proactively take steps to deliver improved healthcare access and solutions.

The healthcare sector is rapidly adopting new technologies. Since the onset of COVID-19, the global internet of things market is projected to grow at a CAGR of 15.9% from $39.3 billion in 2020 to $172.4B by 2030 and Telemedicine is expected to exceed this to reach $244B by 2032.

The TriAge Assistant offers a cost-effective and rapid ability to integrate AI algorithms and applications, enhancing the UniDoc value proposition for healthcare providers. This streamlined approach empowers commercial partners to leverage cutting-edge AI technologies without significant infrastructure investments, ultimately improving patient outcomes and reducing the cost of clinical care.

On Behalf of the Board of Directors,

~Antonio Baldassarre~

Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.

About UniDoc Health Corp. (CSE:UDOC) (FRA:L7T) (OTC PINK:UDOCF)

UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician’s office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company’s belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.

For further information, please contact:

UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com

Matt Chatterton, Director
Tel: +1 778.613.2082
Email: matt@unidoctor.com

Media Inquiries media@unidoctor.com

Forward-Looking Statements

This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “will be”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the integration of DocBox AI technology into the Company’s products and the benefits therefrom.

Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company’s ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company’s annual management discussion and analysis dated July 29, 2022 under the heading “Risks Factors.” Accordingly, readers should not place undue reliance on any such forward-looking information.

Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

SOURCE: UniDoc Health Corp.

View source version on accesswire.com:
https://www.accesswire.com/768105/UniDoc-Introduces-Artificial-Intelligence-AI-Integration

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

2 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

16 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

17 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

17 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

18 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

20 hours ago